Step I Thyroxine and HMG Coa Reductase

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.
Get help with your application

Use all the free resources available to you from SDN: articles, guides, expert advising, forums discussions, and school research.

"Despite the increased activity of the HMG-CoA reductase, levels of TC, LDL-C, ApoB and Lp(a) tend to decrease in patients with clinical or subclinical hyperthyroidism. This is due to increased LDL receptor gene expression resulting in enhanced LDL receptor-mediated catabolism of LDL particles."

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109527/

So despite thyroid hormones upregulating HMG-CoA reductase, an upregulation in lipoprotein lipases helps clear all that, hence the hypocholesterolemia.
 
So FA2014 has Insulin and Thyroxine as upregulators of HMG-CoA reductase...

yet Pathoma says hyperthyroidism leads to hypocholesterolemia

and is corroborated by this

http://www.ncbi.nlm.nih.gov/pubmed/3784912

Any one have any insight?

Maybe I'm misreading that study, but...

Cholesterol synthesis, as estimated by HMG-CoA reductase activity, was decreased in the liver of hypothyroid animals. Thyroxine administration, however, significantly increased reductase activity returning it to control levels